SCHEMBL23861568

SCHEMBL23861568

CC(c1ccc(C(C)(c2cc(O)c3cccc(O)c3c2)c2cc(O)c3cccc(O)c3c2)cc1)(c1cc(O)c2cccc(O)c2c1)c1cc(O)c2cccc(O)c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 4/20 0.46
▸ ESR2 Q92731 3/20 0.46
▸ CDK2 P24941 1/20 0.44
▸ HPGD P15428 3/20 0.41
▸ HSD17B10 Q99714 3/20 0.41
▸ ALOX15 P16050 2/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ IDO1 P14902 2/20 0.39
▸ HDAC4 P56524 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39
▸ HDAC8 Q9BY41 1/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ APP P05067 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ SNCA P37840 1/20 0.39
▸ RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23861453 0.95 ESR1 (0.42) ESR1ESR2CDK2HPGDHSD17B10
SCHEMBL23861542 0.93 ESR1 (0.51) ESR1ESR2CDK2HPGDHSD17B10
SCHEMBL23861439 0.74 ESR1 (0.50) ESR1ESR2HPGDHSD17B10ALOX15
SCHEMBL23861564 0.74 KCNJ11 (0.42) ESR1ESR2CDK2HPGDHSD17B10
SCHEMBL23861622 0.73 ESR1 (0.46) ESR1ESR2HPGDHSD17B10ALOX15
SCHEMBL23861570 0.73 IDO1 (0.44) ESR1ESR2CDK2HPGDHSD17B10
SCHEMBL1314866 0.72 IDO1 (0.60) ESR1ESR2CDK2HPGDHSD17B10
SCHEMBL9232253 0.71 LMNA (0.48) ESR1ESR2CDK2HPGDHSD17B10
SCHEMBL29351230 0.71 IDO1 (0.73) ESR1ESR2CDK2HPGDHSD17B10
SCHEMBL4869305 0.71 IDO1 (0.73) ESR1ESR2CDK2HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method RER1, NBAS, INTS9 ESR1 713/4885ESR2 1033/4885CDK2 3556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback